*Biotechnological challenges ”How to improve the bioavailability and tolerability of the phytotherapeutic P2Et obtained from Caesalpinia spinosa, through the development of a new delivery system, to avoid adverse gastrointestinal events in cancer patients ?” (2020) – Executor. Call Bio-B Program. Financing entities: Connect Bogotá Region – IDB.
*Biotechnological challenges. «How to protect patients undergoing radiotherapy treatment from tissue damage (radiodermatitis) with cosmetic products developed from biodiversity?” (2020) – Executant. Call Bio-B Program. Financing entities: Connect Bogota Region – IDB
